Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Safety and effectiveness of Lutetium-177–Prostate-Specific Membrane Antigen in patients with metastatic castration-resistant prostate cancer with and without visceral metastases who had received prior radium-223: a post hoc analysis of the RALU study

Kambiz Rahbar MD, Markus Essler, Matthias Eiber, Christian la Fougère, Vikas Prasad, Kim Pabst, Wolfgang Fendler, Philipp Rassek, Ergela Hasa, Helmut Dittmann, Ralph Bundschuh, Milena Kurtinecz, Anja Schmall, Frank Verholen and Oliver Sartor
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P607;

Article Information

vol. 64 no. supplement 1 P607
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.
Copyright & Usage 
© 2023

Author Information

  1. Kambiz Rahbar MD1,
  2. Markus Essler2,
  3. Matthias Eiber3,
  4. Christian la Fougère4,
  5. Vikas Prasad5,
  6. Kim Pabst6,
  7. Wolfgang Fendler7,
  8. Philipp Rassek8,
  9. Ergela Hasa9,
  10. Helmut Dittmann4,
  11. Ralph Bundschuh10,
  12. Milena Kurtinecz11,
  13. Anja Schmall12,
  14. Frank Verholen12 and
  15. Oliver Sartor13
  1. 1Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
  2. 2Department of Nuclear Medicine, University Hospital Bonn
  3. 3Technical University Munich
  4. 4Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tübingen, Tübingen, Germany
  5. 5Department of Nuclear Medicine, University of Ulm
  6. 6Department of Nuclear Medicine, West German Cancer, University Hospital Essen, Essen, Germany
  7. 7University Hospital Essen
  8. 8Department of Nuclear Medicine, University of Münster Medical Center, Münster, Germany
  9. 9Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
  10. 10Nuclear Medicine, Faculty of Medicine, University Hospital Augsburg, Augsburg, Germany
  11. 11Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA
  12. 12Bayer Consumer Care, Basel, Switzerland
  13. 13Tulane Cancer Center, Tulane Medical School, New Orleans, USA

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023200
Sep 20232100
Oct 20231900
Nov 20232900
Dec 20232200
Jan 20241900
Feb 20241800
Mar 20241400
Apr 20245000
May 20242200
Jun 20246900
Jul 202411400
Aug 202410300
Sep 20242100
Oct 20244200
Nov 20243600
Dec 20242700
Jan 20253900
Feb 20254000
Mar 20253800
Apr 20255900
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section